| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |